Shopping Cart
- Remove All
Your shopping cart is currently empty
2-({[2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)pyrimidine-4,6-diamine can be used in the development of new deoxycytidine kinase (dCK) inhibitors.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $82 | In Stock | |
| 5 mg | $188 | In Stock | |
| 10 mg | $281 | In Stock | |
| 25 mg | $461 | In Stock | |
| 50 mg | $648 | In Stock | |
| 100 mg | $870 | In Stock | |
| 200 mg | $1,170 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $205 | In Stock |
| Description | 2-({[2-(4-ethoxy-3-methoxyphenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)pyrimidine-4,6-diamine can be used in the development of new deoxycytidine kinase (dCK) inhibitors. |
| Targets&IC50 | DCK deoxycytidine kinase (house mouse):1.12µm |
| Molecular Weight | 389.5 |
| Formula | C17H19N5O2S2 |
| Cas No. | 1209784-87-1 |
| Smiles | O(C)C=1C=C(C=CC1OCC)C2=NC(CSC=3N=C(N)C=C(N)N3)=CS2 |
| Relative Density. | 1.41 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (141.21 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.